Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sialic acid-containing glycan receptors are molecular structures found on the surface of cells, characterized by the presence of sialic acids at the terminal positions of their glycan (sugar) chains. Sialic acids are a family of nine-carbon acidic monosaccharides, most commonly N-acetylneuraminic acid (Neu5Ac), that impart a negative charge and hydrophilic properties to glycoconjugates such as glycoproteins and glycolipids. These receptors play crucial roles in cell–cell communication, immune regulation, and host–pathogen interactions.
The interaction between a receptor (e.g., Siglec) and its ligand (sialoglycan) is determined by: - The conformation/flexibility dictated by specific glycosidic linkages - Additional sugar residues adjacent to the terminal Neu5Ac - Specific amino acid contacts within the receptor’s binding site
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sialic Acid-Containing Glycan Receptor.